Cargando…
Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics
BACKGROUND: Pharmacological modulation of metabotropic glutamate receptor 5 (mGluR5) is of marked interest as a novel therapeutic mechanism to treat schizophrenia and major depression. However, the status of mGluR5 in the pathophysiology of these disorders remains unknown. DISCUSSION: The majority o...
Autores principales: | Newell, Kelly A, Matosin, Natalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907147/ https://www.ncbi.nlm.nih.gov/pubmed/24472577 http://dx.doi.org/10.1186/1471-244X-14-23 |
Ejemplares similares
-
PM491. The Neurodevelopmental Profile of Group 1 Metabotropic Glutamate Receptors: Implications for Novel Therapeutics
por: Lum, Jeremy S., et al.
Publicado: (2016) -
Editorial: Metabotropic Glutamate Receptors and Neurological/Psychiatric Disorders
por: Palazzo, Enza, et al.
Publicado: (2019) -
Rethinking Disability
por: Cieza, Alarcos, et al.
Publicado: (2018) -
Metabotropic Glutamate Receptors: Potential Drug Targets for Psychiatric Disorders
por: Yasuhara, Akito, et al.
Publicado: (2010) -
Ether in the developing world: rethinking an abandoned agent
por: Chang, Connie Y., et al.
Publicado: (2015)